The challenge of removal of sepsis markers by continuous hemofiltration
- PMID: 31092274
- PMCID: PMC6521397
- DOI: 10.1186/s13054-019-2464-z
The challenge of removal of sepsis markers by continuous hemofiltration
Conflict of interest statement
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Comment on
-
The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis - a secondary analysis of a large randomised controlled trial.Crit Care. 2018 Mar 21;22(1):79. doi: 10.1186/s13054-018-2001-5. Crit Care. 2018. PMID: 29562917 Free PMC article. Clinical Trial.
References
-
- Elke G, Bloos F, Wilson DC, Brunkhorst FM, Briegel J, Reinhart K, et al. The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis - a secondary analysis of a large randomised controlled trial. Crit Care. 2018;22:79. doi: 10.1186/s13054-018-2001-5. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
